As director of the Chao Family Comprehensive Cancer Center at the University of California Irvine Medical Center, Dr. Frank Meyskens Jr, MD, has helped transform UC Irvine into one of the nation’s premier cancer centers, especially in prevention and early diagnosis. His research on the novel compound combination of DFMO/Sulindac has shown to prevent the development of colon cancer. If you thought this stuff was over your head, let Dr. Meyskens take you through it, in this fully understandable and engaging interview.

Subscribe with your favorite podcast player

The post Medicine On The Cutting Edge – A Pill to Prevent Colon Cancer May Not Be Far Away appeared first on WebTalkRadio.net.